Login
|
New Account
AAAAAA
ITA
ENG
Results:
<<
|
101-125
|
126-150
|
151-175
|
176-200
|
>>
Table of contents of journal:
*Formulary (Cleveland, Ohio)
Results: 151-175/696
GUIDELINES FOR PHOSPHORUS SUPPLEMENTATION IN ADULTS
Citation:
GUIDELINES FOR PHOSPHORUS SUPPLEMENTATION IN ADULTS, Formulary, 33(3), 1998, pp. 263-263
PROTOCOL FOR AUTOMATIC ANTIBIOTIC DOSE ADJUSTMENT BASED ON RENAL-FUNCTION
Citation:
PROTOCOL FOR AUTOMATIC ANTIBIOTIC DOSE ADJUSTMENT BASED ON RENAL-FUNCTION, Formulary, 33(3), 1998, pp. 263-264
ENOXAPARIN PROTOCOL APPROVED FOR TREATING UNCOMPLICATED DVT
Citation:
ENOXAPARIN PROTOCOL APPROVED FOR TREATING UNCOMPLICATED DVT, Formulary, 33(3), 1998, pp. 264-264
FORMULARY SELECTIONS MADE AMONG HMG-COA REDUCTASE INHIBITORS
Citation:
FORMULARY SELECTIONS MADE AMONG HMG-COA REDUCTASE INHIBITORS, Formulary, 33(3), 1998, pp. 264-264
PROPOSED FDA POLICIES AFFECT DRUG MARKETING TO HEALTH PLANS AND FORMULARY COMMITTEES
Authors:
WECHSLER J
Citation:
J. Wechsler, PROPOSED FDA POLICIES AFFECT DRUG MARKETING TO HEALTH PLANS AND FORMULARY COMMITTEES, Formulary, 33(3), 1998, pp. 266
FARESTON - ANTIESTROGEN FOR TREATING BREAST-CANCER IN POSTMENOPAUSAL WOMEN
Citation:
FARESTON - ANTIESTROGEN FOR TREATING BREAST-CANCER IN POSTMENOPAUSAL WOMEN, Formulary, 33(2), 1998, pp. 90-90
FORTOVASE - SOFT GEL FORMULATION OF PROTEASE INHIBITOR SAQUINAVIR FORHIV-INFECTION
Citation:
FORTOVASE - SOFT GEL FORMULATION OF PROTEASE INHIBITOR SAQUINAVIR FORHIV-INFECTION, Formulary, 33(2), 1998, pp. 90-91
PLAVIX - PLATELET INHIBITOR FOR REDUCING OVERALL RISK OF ATHEROSCLEROTIC EVENTS
Citation:
PLAVIX - PLATELET INHIBITOR FOR REDUCING OVERALL RISK OF ATHEROSCLEROTIC EVENTS, Formulary, 33(2), 1998, pp. 91
NEUMEGA - RECOMBINANT INTERLEUKIN-11 FOR PREVENTING SEVERE THROMBOCYTOPENIA
Citation:
NEUMEGA - RECOMBINANT INTERLEUKIN-11 FOR PREVENTING SEVERE THROMBOCYTOPENIA, Formulary, 33(2), 1998, pp. 91-91
MERIDIA - ANORECTIC AGENT FOR TREATING OBESITY
Citation:
MERIDIA - ANORECTIC AGENT FOR TREATING OBESITY, Formulary, 33(2), 1998, pp. 91-91
CIPRO-IV - IN COMBINATION WITH PIPERACILLIN TO TREAT FEBRILE NEUTROPENIC PATIENTS
Citation:
CIPRO-IV - IN COMBINATION WITH PIPERACILLIN TO TREAT FEBRILE NEUTROPENIC PATIENTS, Formulary, 33(2), 1998, pp. 95-96
ZOMIG - 5-HT AGONIST FOR MIGRAINE HEADACHES
Citation:
ZOMIG - 5-HT AGONIST FOR MIGRAINE HEADACHES, Formulary, 33(2), 1998, pp. 95-95
RITUXAN - MONOCLONAL-ANTIBODY FOR TREATMENT OF NON-HODGKINS-LYMPHOMA
Citation:
RITUXAN - MONOCLONAL-ANTIBODY FOR TREATMENT OF NON-HODGKINS-LYMPHOMA, Formulary, 33(2), 1998, pp. 95-95
TRANSDERM SCOP - PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH ANESTHESIA AND SURGERY
Citation:
TRANSDERM SCOP - PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH ANESTHESIA AND SURGERY, Formulary, 33(2), 1998, pp. 96-96
ZOCOR - INDICATION EXPANDED TO INCLUDE REDUCTION OF TRIGLYCERIDE LEVELS
Citation:
ZOCOR - INDICATION EXPANDED TO INCLUDE REDUCTION OF TRIGLYCERIDE LEVELS, Formulary, 33(2), 1998, pp. 96-96
ACULAR - PRESERVATIVE-FREE FORMULATION FOR OCULAR PAIN AND PHOTOPHOBIA
Citation:
ACULAR - PRESERVATIVE-FREE FORMULATION FOR OCULAR PAIN AND PHOTOPHOBIA, Formulary, 33(2), 1998, pp. 96
NIZORAL SHAMPOO - TREATMENT OF TINEA-VERSICOLOR
Citation:
NIZORAL SHAMPOO - TREATMENT OF TINEA-VERSICOLOR, Formulary, 33(2), 1998, pp. 96-96
EFFEXOR XR - EXTENDED-RELEASE CAPSULE FORMULATION FOR ONCE-DAILY ADMINISTRATION
Citation:
EFFEXOR XR - EXTENDED-RELEASE CAPSULE FORMULATION FOR ONCE-DAILY ADMINISTRATION, Formulary, 33(2), 1998, pp. 99-99
FLOVENT, FLONASE - DRY POWDER FORMULATION FOR INHALATION, PEDIATRIC USE FOR THE NASAL SPRAY
Citation:
FLOVENT, FLONASE - DRY POWDER FORMULATION FOR INHALATION, PEDIATRIC USE FOR THE NASAL SPRAY, Formulary, 33(2), 1998, pp. 99-99
COMBIVIR - LAMIVUDINE-ZIDOVUDINE COMBINATION IN A SINGLE TABLET FOR HIV-INFECTION
Citation:
COMBIVIR - LAMIVUDINE-ZIDOVUDINE COMBINATION IN A SINGLE TABLET FOR HIV-INFECTION, Formulary, 33(2), 1998, pp. 99-99
HMO SURVEY REVEALS SOARING PMPM DRUG SPENDING, WIDESPREAD SHARING OF PRESCRIPTION BENEFIT RISK
Citation:
HMO SURVEY REVEALS SOARING PMPM DRUG SPENDING, WIDESPREAD SHARING OF PRESCRIPTION BENEFIT RISK, Formulary, 33(2), 1998, pp. 100-100
BIPHOSPHONATES EFFECTIVE FOR STEROID-INDUCED OSTEOPOROSIS
Citation:
BIPHOSPHONATES EFFECTIVE FOR STEROID-INDUCED OSTEOPOROSIS, Formulary, 33(2), 1998, pp. 103-103
TNF INHIBITOR PROMISES SAFER RHEUMATOID-ARTHRITIS THERAPY
Citation:
TNF INHIBITOR PROMISES SAFER RHEUMATOID-ARTHRITIS THERAPY, Formulary, 33(2), 1998, pp. 103-103
FOCUS ON QUETIAPINE - THE 4TH ATYPICAL ANTIPSYCHOTIC
Authors:
CALEY CF ROSENBAUM S
Citation:
Cf. Caley et S. Rosenbaum, FOCUS ON QUETIAPINE - THE 4TH ATYPICAL ANTIPSYCHOTIC, Formulary, 33(2), 1998, pp. 105
SECONDARY PREVENTION THERAPY IN PATIENTS WITH CORONARY-ARTERY DISEASE
Authors:
DHOND M AMSTERDAM EA
Citation:
M. Dhond et Ea. Amsterdam, SECONDARY PREVENTION THERAPY IN PATIENTS WITH CORONARY-ARTERY DISEASE, Formulary, 33(2), 1998, pp. 120
Risultati:
<<
|
101-125
|
126-150
|
151-175
|
176-200
|
>>